17.5% to 5.2% and that of cirrhosis cases from 26.4% to 4.1%. Instead, in the over-60 age group the rate of inactive carriers increased from 22.8% to 41.2% and that of chronic hepatitis from 16.8% to 46%; the rate of patients with cirrhosis ranged from 5% to 8% in different studies.
Conclusion: Twenty-three years after the introduction universal HBV vaccination in
Italy, the clinical presentation of CLD had shown a shift toward older ages and more severe diseases. Italian patients with CLD showed that 23.2% were HBsAg-positive. In 2014 a further survey on 2557 subjects with CLD was performed. 4 The present paper describes the demographic and clinical data of the 513 subjects who were HBsAg-positive, and analyzes the changes in the demographics and clinical presentation occurring in Italy in the last 4 decades. More importantly, we analyzed the impact of universal HBV vaccination on the burden of HBsAg-positive CLD in
Italy more than 23 years after its introduction.
| PATIENTS AND METHODS
The original database comprised all consecutive patients with CLD seen in 16 Italian liver units during the year 2014 as inpatients or outpatients. For the purpose of the present analysis, we retrieved all HBsAg-positive carriers aged over 18. Most of the participating liver units have cooperated in previous clinical investigations, and applied the same clinical approach and laboratory methods. The study design and method was described in detail in a previous study. 4 The diagnosis of chronic hepatitis was based on liver histology in nearly 80% of the cases and on the persistence of ALT elevation for 6 months or more in the remaining 20% in the absence of biochemical and ultrasound or transient evidence of liver cirrhosis. 5 Liver cirrhosis was diagnosed based on liver histology or, in patients who did not undergo liver biopsy, on the presence of the peculiar clinical, biochemical, and ultrasound or transient signs. 5 According to accepted criteria, hepatocellular carcinoma (HCC) was diagnosed based on histological and/or imaging findings and on serum α-fetoprotein (AFP) levels. 6 The presence of serum HBsAg identified the HBV etiology, whereas the detection also of the antibody to HDV identified HBV/ HDV coinfection and the detection of the antibody to HCV identified HBC/HCV coinfection; HBsAg positivity and alcohol abuse defined HBV/alcohol abuse. Alcohol abuse was defined as an intake of more than four alcoholic drinks per day over 5 years or more, whereas social drinking was a daily intake of 1-4 alcoholic beverages. 7, 8 An echo-assisted percutaneous liver biopsy was performed when required by the physician in care for diagnostic purposes. In each liver unit a skilled pathologist unaware of the clinical and laboratory data evaluated liver histology. In particular, liver necroinflammation and fibrosis were assessed by the Ishak 9 or Metavir scoring system 10 and standardized criteria were used to convert the Ishak scores to Metavir scores. 11 Transient elastometry was performed by Fibroscan 12-14 and used as an alternative method to assess liver fibrosis. 
| Statistical analysis
The data were collected in a pre-established electronic CRF database (web-based data collection, e-CRF provided by Air-Tel®, Airon
Telematica, Milan, ITALY). Categorical variables were summarized as absolute counts and proportions. Differences in proportion were evaluated by the chi square test or Fisher's exact test. A P-value < 0.05 was considered to be significant. All P values were two-tailed.
| RESULTS
The 513 patients with HBV chronic infection enrolled in the present study were prevalently males (sex ratio = Table 3) . 
| DISCUSSION
One of the major aims of the HBV vaccination campaign was the reduction in the burden of HBsAg-positive CLD, including HCC.
Population surveys performed in Taiwan on children born before and after the introduction of universal HBV vaccination showed a drastic decrease in the HBV carrier rate and infection rate among subjects born since the program began. 16 Moreover, studies on the secular trend of liver disease documented a 68% decline in mortality from fulminant hepatitis in infants and a 75% decrease in the incidence of HCC in children 6-9 years old after the introduction of a national vaccination program. 17 Similarly, substantial reductions in newly acquired HBV infections, HBsAg carrier rate and HBV-related mortality have been reported in countries where universal vaccination has been implemented, such as Alaska 18 and Gambia. 19 In Italy, the data from the national surveillance system for viral hepatitis (SEIEVA) indicate a marked decrease in the incidence of acute B hepatitis in the age-groups covered by vaccination (Fig. 1) . This is in In conclusion, this study provides evidence of the effectiveness of universal HBV vaccination in preventing chronic liver disease among the youngest generations 23 years after its launch in Italy.
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